BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 6274191)

  • 1. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V; Hein R; Ring J; Möhrenschlager M
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical diagnosis of Anderson-Fabry disease in two brothers].
    Vidershaĭn GIa; Beĭer EM; Mendel'son MM; Livandovskiĭ IuA
    Vopr Med Khim; 1986; 32(5):120-3. PubMed ID: 3095985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.
    Peltier A; Herbeuval E; Brondeau MT; Belleville F; Nabet P
    Biomedicine; 1977 May; 26(3):194-201. PubMed ID: 407951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical study of unusual cases of Fabry disease].
    Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
    Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of Fabry's disease].
    Mendel'son MM; Livandovskiĭ IuA; Vidershaĭn GIa; Bruk EI; Il'ina GS
    Ter Arkh; 1987; 59(8):137-41. PubMed ID: 3120344
    [No Abstract]   [Full Text] [Related]  

  • 9. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
    Germain DP; Poenaru L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of conjunctival biopsy and enzyme analysis in tears for the diagnosis of homozygotes and heterozygotes with Fabry disease.
    Libert J; Tondeur M; Van Hoof F
    Birth Defects Orig Artic Ser; 1976; 12(3):221-39. PubMed ID: 821559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudodeficiency of alpha-galactosidase A.
    Bach G; Rosenmann E; Karni A; Cohen T
    Clin Genet; 1982 Jan; 21(1):59-64. PubMed ID: 6279339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].
    Sakuraba H
    Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles.
    Spence MW; Goldbloom AL; Burgess JK; D'entremont D; Ripley BA; Weldon KL
    J Med Genet; 1977 Apr; 14(2):91-9. PubMed ID: 404411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hurler syndrome: alpha-L-iduronidase activity in leukocytes as a method for heterozygote detection.
    Wappner RS; Brandt IK
    Pediatr Res; 1976 Jun; 10(6):629-32. PubMed ID: 818611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R; Olea T
    Nefrologia; 2002; 22(6):540-6. PubMed ID: 12516287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.
    Hagège AA; Caudron E; Damy T; Roudaut R; Millaire A; Etchecopar-Chevreuil C; Tran TC; Jabbour F; Boucly C; Prognon P; Charron P; Germain DP;
    Heart; 2011 Jan; 97(2):131-6. PubMed ID: 21062768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.
    Morgan SH; Rudge P; Smith SJ; Bronstein AM; Kendall BE; Holly E; Young EP; Crawfurd MD; Bannister R
    Q J Med; 1990 May; 75(277):491-507. PubMed ID: 2167495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes.
    Ishii S; Sakuraba H; Shimmoto M; Minamikawa-Tachino R; Suzuki T; Suzuki Y
    Ann Neurol; 1991 May; 29(5):560-4. PubMed ID: 1650161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.